New Seed Tampa Bay fund aims to be the ‘first money in’ for tech startups
TAMPA BAY, FL. – About 18 months after winning a federal grant to create an investment fund for young companies, Seed Tampa Bay Early Stage Investment Fund LLC is preparing to launch. The early-stage fund will invest in a broad range of technologies being developed by startups in the region, said Valerie McDevitt, associate vice president for technology transfer and business partnerships at University of South Florida. Early-stage funding is critical to growing and sustaining a strong technology sector and the employment and economic activity that comes with it. “We don’t want...
Read MoreEmergo Therapeutics Raises $12 Million, Mostly from NC Investors
DURHAM, N.C. – Moise Khayrallah, Ph.D., is a serial entrepreneur with a Midas touch. Three biopharmaceutical start-ups he co-founded in recent years were quickly sold to larger companies for more than $400 million after he and his teams built their value from scratch. His latest startup, Durham-based Emergo Therapeutics, could be on a similar path after raising $12 million in venture capital this spring, mostly from North Carolina investors. “For me, this is a huge shot in the arm, not just for us as a company but for the entrepreneurial community in our area,” says Khayrallah,...
Read MoreAxoGen Chairman and CEO Karen Zaderej Named Entrepreneur Of The Year 2018 Award Winner in Florida
ALACHUA, FL. – AxoGen, Inc. (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerves, today announced that Ernst & Young (EY) named AxoGen Chairman and CEO Karen Zaderej as the Entrepreneur Of The Year® 2018 Award winner in the Health Care category in Florida. The awards program recognizes entrepreneurs who are excelling in areas such as innovation, financial performance and personal commitment to their businesses and communities. Zaderej was selected as an award winner by a panel of independent judges. Award winners were...
Read MoreTapImmune Announces Pricing of $70 Million Private Placement
JACKSONVILLE, FL. – TapImmune Inc. (NASDAQ: TPIV), a clinical-stage immuno-oncology company, today announced that it has entered into security purchase agreements with certain institutional and accredited investors in connection with a private placement of its equity securities. The private placement will be led by New Enterprise Associates (NEA) with participation from Aisling Capital and Perceptive Advisors, among other new and existing investors. The private placement is expected to be completed concurrently with the closing of the proposed merger between TapImmune Inc. and...
Read MorePfizer devotes $150 million to neuroscience in venture capital funding increase
New York-based drugmaker Pfizer is kicking $600 million in new funding into its venture capital arm, one-quarter of which will go toward early-stage neuroscience companies. The company said Wednesday that the fund would also hire new staff, with expertise in drug discovery, clinical development, venture capital investing and business development. The neuroscience component of the new funding will be focused on neuro-degenerative, neuro-inflammatory and neuro-metabolic disorders. Pfizer Ventures’ portfolio includes more than 40 companies and, with $500 million invested to date, the new...
Read MorePharma startup Emergo lands $12M
DURHAM, N.C. – An all-star list of Triangle investors is backing Durham pharmaceutical startup Emergo Therapeutics with $12 million in venture capital. Leading the round, which was announced recently, is REX Health Ventures. Other backers include: Wolfpack Investor Network Carolina Angel Network Hatteras Venture Partners’ Venture Capital Multiplier Fund Emergo is developing treatment options for flu-like illnesses and to boost the body’s immune system response. REX has already worked with the company in assessing its technology. “REX Health Ventures is proud to support...
Read More
Follow Us!